The protein electrophoresis market has seen considerable growth due to a variety of factors.
• The market size for protein electrophoresis has seen substantial growth in recent times. Predictions suggest that it will rise from $2.94 billion in 2024 to $3.14 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.7%.
This growth during the historic phase is mainly due to the rising incidences of chronic illnesses and genetic abnormalities, an increase in research and development in proteomics, and advancements in electrophoresis technology.
The protein electrophoresis market is expected to maintain its strong growth trajectory in upcoming years.
• Sturdy growth is anticipated in the protein electrophoresis market size in the upcoming years, with expectations to reach $4.02 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.4%.
This forecast period growth is primarily due to the advent of integrated multi-omics technologies with electrophoresis, heightened investments in the biotechnology and pharmaceutical research sectors, an increasing emphasis on precision medicine and targeted therapies, the broadening of applications in clinical diagnostics and therapeutic monitoring, and the evolution of automatic and high-throughput electrophoresis systems. Key trends in the forecast period include the fusion of artificial intelligence and machine learning, the advent of sophisticated microfluidics, the creation of portable and user-friendly electrophoresis devices for point-of-care testing, applications in personalized and precision medicine, and improvements in software.
Growth in the protein electrophoresis market is anticipated due to an increase in cancer cases. Factors such as aging populations, lifestyle shifts, environmental influences, and enhanced diagnostic procedures contribute to the escalation in cancer rates. Protein electrophoresis benefits cancer patients by identifying irregular proteins in the blood, which assists in the diagnosis, monitoring, and treatment of specific cancers. In April 2024, the France-based International Agency for Research on Cancer (IARC) and the US-based non-profit American Cancer Society (ACS), which focuses on cancer prevention and raising awareness, disclosed that around 20 million new cancer cases were reported worldwide in 2022. The report further forecasted a 77% surge, predicting that cases could hit 35 million per year by 2050. Lung cancer was the most frequently diagnosed, accounting for 12.4% of cases, followed by breast cancer at 11.6% and colorectal cancer at 9.6%. Lung cancer also led to the most fatalities, with 1.8 million deaths (18.7%), trailed by colorectal cancer at 9.3% and liver cancer at 7.8%. Consequently, the growing incidence of cancer will fuel the expansion of the protein electrophoresis market.
The protein electrophoresis market covered in this report is segmented –
1) By Type: Serum Protein Electrophoresis, Immunostationary Electrophoresis, Isoenzyme Electrophoresis, Lipoprotein Electrophoresis, Hemoglobin Electrophoresis, Glycosylated Hemoglobin Electrophoresis, Non-Concentrated Urine Protein Electrophoresis, Cerebrospinal Fluid Electrophoresis
2) By Technique: Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-Page), Native Page, 1-D Page, 2-D Page
3) By Gel: Agarose Gel Electrophoresis, Polyacrylamide Gel Electrophoresis
4) By Application: Protein Analysis, Molecular Biology, Clinical Diagnostics
5) By End-User: Hospitals And Diagnostics, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users
Subsegments:
1) By Serum Protein Electrophoresis (SPEP): Albumin Electrophoresis, Globulin Electrophoresis (Alpha-1, Alpha-2, Beta, And Gamma), Monoclonal Gammopathy Identification, Serum-Free Light Chain Assay (sFLC), Paraprotein Detection, Protein Fractions Analysis
2) By Immunostationary Electrophoresis (Immunoelectrophoresis): Immunofixation Electrophoresis (IFE), Rocket Immunoelectrophoresis, Counter Immunoelectrophoresis, Two-Dimensional Immunoelectrophoresis, Immunoblotting Techniques, Western Blotting
3) By Isoenzyme Electrophoresis: Lactate Dehydrogenase (LDH) Isoenzyme Electrophoresis, Creatine Kinase (CK) Isoenzyme Electrophoresis, Alkaline Phosphatase Isoenzyme Electrophoresis, Amylase Isoenzyme Electrophoresis, Glutamate Dehydrogenase (GDH) Isoenzyme Electrophoresis, Malate Dehydrogenase (MDH) Isoenzyme Electrophoresis
4) By Lipoprotein Electrophoresis: High-Density Lipoproteins (HDL), Low-Density Lipoproteins (LDL), Very Low-Density Lipoproteins (VLDL), Chylomicrons, Intermediate-Density Lipoproteins (IDL)
5) By Hemoglobin Electrophoresis: Normal Hemoglobin (HbA, HbA2), Sickle Cell Hemoglobin (HbS), Hemoglobin C (HbC), Hemoglobin D (HbD), Thalassemia (HbF, HbH, Hb Bart’s), Hemoglobin E (HbE)
6) By Glycosylated Hemoglobin Electrophoresis (HbA1c Electrophoresis): Glycated Hemoglobin A1c (HbA1c), Hemoglobin A1a And A1b, Non-Glycated Hemoglobin, Assessment Of Glycemic Control (For Diabetes)
7) By Non-Concentrated Urine Protein Electrophoresis: Albumin Detection, Bence Jones Proteins Detection, Tubular Proteinuria, Glomerular Proteinuria, Tamm-Horsfall Protein, Urinary Monoclonal Free Light Chains (? And ?)
8) By Cerebrospinal Fluid (CSF) Electrophoresis: Oligoclonal Bands Detection (For Multiple Sclerosis Diagnosis), CSF IgG Index, CSF Albumin, CSF/Serum Albumin Ratio, CSF Total Protein Fractionation, CSF Free Light Chain Assay (FLC)
Leading businesses within the protein electrophoresis market are centering their efforts around the creation of innovative products like vertical electrophoresis systems to maintain a competitive advantage. The vertical electrophoresis system, a type of lab equipment, allows the separation of biomolecules like proteins or nucleic acids depending on their size, charge or other distinctive qualities via gel electrophoresis. To illustrate, TransGen Biotech Co. Ltd., a French manufacturer of molecular and cellular biology reagents, rolled out the TSE-P Mini Vertical Electrophoresis System in November 2023. The system is engineered to allow effective protein separation and transfer, giving researchers the possibility to explore the composition, diversity, and interactions of proteins within samples. The unit can separate proteins or nucleic acids based on their charge and size. Suitable for both pre-cast and hand-cast gels, it is adaptable to a range of gel thicknesses and well dimensions. The system further includes a transfer system that effectively moves separated proteins or nucleic acids from the gel onto a membrane (like nitrocellulose) for additional investigation or detection.
Major companies operating in the protein electrophoresis market are:
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Laboratory Corporation of America Holdings
• Proteome Sciences PLC
• Lonza Group Ltd.
• Agilent Technologies Inc.
• VWR International
• Beckman Coulter Inc.
• Shimadzu Corporation
• PerkinElmer Inc.
• Bio-Rad Laboratories Inc.
• QIAGEN N.V.
• Helena Laboratories Corporation
• Syngene International Ltd.
• Takara Bio Inc.
• Analytik Jena
• Sebia Group
• LabRepCo LLC
• Serva Electrophoresis GmbH
• Cleaver Scientific Ltd.
• C.B.S. Scientific Company
North America was the largest region in the protein electrophoresis market in 2024. The regions covered in the protein electrophoresis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.